2014
DOI: 10.1021/jm501179r
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of Potent KIFC1 Inhibitors Using a Method of Integrated High-Throughput Synthesis and Screening

Abstract: KIFC1 (HSET), a member of the kinesin-14 family of motor proteins, plays an essential role in centrosomal bundling in cancer cells, but its function is not required for normal diploid cell division. To explore the potential of KIFC1 as a therapeutic target for human cancers, a series of potent KIFC1 inhibitors featuring a phenylalanine scaffold was developed from hits identified through high-throughput screening (HTS). Optimization of the initial hits combined both design-synthesis-test cycles and an integrate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
31
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(31 citation statements)
references
References 36 publications
0
31
0
Order By: Relevance
“…To date, only two groups have reported specific KIFC1 inhibitors in the literature (37,43,44). Scientists at AstraZeneca identified a small molecule KIFC1 inhibitor, AZ82, which inhibited MT-stimulated KIFC1 ATPase activity with an IC 50 of 0.3 μM and triggered multipolar spindle formation and mitotic catastrophe in cells with amplified centrosomes.…”
Section: Discussionmentioning
confidence: 99%
“…To date, only two groups have reported specific KIFC1 inhibitors in the literature (37,43,44). Scientists at AstraZeneca identified a small molecule KIFC1 inhibitor, AZ82, which inhibited MT-stimulated KIFC1 ATPase activity with an IC 50 of 0.3 μM and triggered multipolar spindle formation and mitotic catastrophe in cells with amplified centrosomes.…”
Section: Discussionmentioning
confidence: 99%
“…The AZ82 inhibitor of HSET was a gift from AstraZeneca (USA) [29][30]. AZ82 was stored diluted in DMSO at 100 lM and further diluted in M2 medium to a final concentration of 10 lM.…”
Section: Drug Treatmentmentioning
confidence: 99%
“…In addition to the CuAAC reaction, various other reactions are available, including copper-free click reactions [79,80], thiol-ene click chemistry [81], metal-mediated amine-to-nitrile addition [84], amide-forming reaction [85,86], epoxide opening [87] and many other reactions for click chemistry [88]; and many of these are rapid, highly Owing to their excellent specificity and rapid reaction rate, we anticipate that many of these newly disclosed reactions will be effective substitutes for CuAAC and, in combination with HT in situ assay technologies, will further revolutionize lead-finding and lead-optimization campaigns in drug discovery.…”
Section: Page 14 Of 30mentioning
confidence: 99%